The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Neurofibromatosis type 1
Open accessAbstract
Neurofibromatosis type 1 (NF1) is an autosomal dominant, multisystem disorder affecting approximately 1 in 3500 people. Significant advances in the understanding of the pathophysiology of NF1 have been made in the last decade. While no medical therapies are currently available, trials are ongoing to discover and test medical treatments for the various manifestations of NF1, primarily plexiform neurofibromas, learning disabilities, and optic pathway gliomas. Additionally, mutational analysis has become available on a clinical basis and is useful for diagnostic confirmation in individuals who do not fulfill diagnostic criteria or when prenatal diagnosis is desired. There are several disorders which may share overlapping features with NF1; in 2007, a disorder with cutaneous findings similar to NF1 was described. This paper addresses the dermatologist's role in diagnosis and management of NF1 and describes the variety of cutaneous and extracutaneous findings in NF1 to which the dermatologist may be exposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gutmann, D. H. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550010065042 · Cited by 1,359
Von Recklinghausen Neurofibromatosis
Riccardi, V. M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112313052704 · Cited by 1,344
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
Evans, D. G. R., Baser, M. E., McGaughran, J., Sharif, S., Howard, E., & Moran, A. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.5.311 · Cited by 1,282
The neurofibromatosis type 1 gene encodes a protein related to GAP
Xu, G., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90024-9 · Cited by 1,095
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
Viskochil, D., Buchberg, A. M., Xu, G., Cawthon, R. M., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90252-a · Cited by 1,082
Neurofibromatosis, Phenotype, Natural History, and Pathogenesis
Riccardi, V. M., & Smirniotopoulos, J. (1992) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199211000-00009 · Cited by 893
VON RECKLINGHAUSEN NEUROFIBROMATOSIS: A CLINICAL AND POPULATION STUDY IN SOUTH-EAST WALES
HUSON, S. M., HARPER, P. S., & COMPSTON, D. A. S. (1988) · Brain · doi:10.1093/brain/111.6.1355 · Cited by 686
The nature and frequency of cognitive deficits in children with neurofibromatosis type 1
Hyman, S. L., Shores, A., & North, K. N. (2005) · Neurology · doi:10.1212/01.wnl.0000179303.72345.ce · Cited by 637
Rapamycin causes regression of astrocytomas in tuberous sclerosis complex
Franz, D. N., Leonard, J., Tudor, C., Chuck, G., Care, M., Sethuraman, G., Dinopoulos, A., Thomas, G., & Crone, K. R. (2006) · Annals of Neurology · doi:10.1002/ana.20784 · Cited by 614
Use of the National Institutes of Health Criteria for Diagnosis of Neurofibromatosis 1 in Children
DeBella, K., Szudek, J., & Friedman, J. M. (2000) · Pediatrics · doi:10.1542/peds.105.3.608 · Cited by 581
Optic pathway gliomas in neurofibromatosis‐1: Controversies and recommendations
Listernick, R., Ferner, R. E., Liu, G. T., & Gutmann, D. H. (2007) · Annals of Neurology · doi:10.1002/ana.21107 · Cited by 576
Listernick, R., Charrow, J., Greenwald, M., & Mets, M. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70122-9 · Cited by 548
A Clinical, Pathological, and Genetic Study of Multiple Neurofibromatosis
(1956) · Journal of the American Medical Association · doi:10.1001/jama.1956.02970230087029 · Cited by 522
Messiaen, L. M., Callens, T., Mortier, G., Beysen, D., Vandenbroucke, I., Van Roy, N., Speleman, F., & Paepe, A. D. (2000) · Human Mutation · doi:10.1002/1098-1004(200006)15:6<541::aid-humu6>3.0.co;2-n · Cited by 521
Listernick, R., Louis, D. N., Packer, R. J., & Gutmann, D. H. (1997) · Annals of Neurology · doi:10.1002/ana.410410204 · Cited by 478
Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1–like phenotype
Brems, H., Chmara, M., Sahbatou, M., Denayer, E., Taniguchi, K., Kato, R., Somers, R., Messiaen, L., De Schepper, S., Fryns, J.-P., et al. (2007) · Nature Genetics · doi:10.1038/ng2113 · Cited by 472
Li, W., Cui, Y., Kushner, S. A., Brown, R. A. M., Jentsch, J. D., Frankland, P. W., Cannon, T. D., & Silva, A. J. (2005) · Current Biology · doi:10.1016/j.cub.2005.09.043 · Cited by 402
(2012) · SpringerReference · doi:10.1007/springerreference_109771 · Cited by 390
The clinical and diagnostic implications mosaicism in the neurofibromatoses
Ruggieri, M., & Huson, S. M. (2001) · Neurology · doi:10.1212/wnl.56.11.1433 · Cited by 387
Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/−- and c-kit-Dependent Bone Marrow
Yang, F.-C., Ingram, D. A., Chen, S., Zhu, Y., Yuan, J., Li, X., Yang, X., Knowles, S., Horn, W., Li, Y., et al. (2008) · Cell · doi:10.1016/j.cell.2008.08.041 · Cited by 364
Upadhyaya, M., Huson, S. M., Davies, M., Thomas, N., Chuzhanova, N., Giovannini, S., Evans, D. G., Howard, E., Kerr, B., Griffiths, S., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/510781 · Cited by 362
Elevated Risk for MPNST in NF1 Microdeletion Patients
De Raedt, T., Brems, H., Wolkenstein, P., Vidaud, D., Pilotti, S., Perrone, F., Mautner, V., Frahm, S., Sciot, R., & Legius, E. (2003) · The American Journal of Human Genetics · doi:10.1086/374821 · Cited by 310
Optic gliomas in children with neurofibromatosis type 1
Listernick, R., Charrow, J., Greenwald, M. J., & Esterly, N. B. (1989) · The Journal of Pediatrics · doi:10.1016/s0022-3476(89)80137-4 · Cited by 307
North, K. N., Riccardi, V., Samango-Sprouse, C., Ferner, R., Moore, B., Legius, E., Ratner, N., & Denckla, M. B. (1997) · Neurology · doi:10.1212/wnl.48.4.1121 · Cited by 269
Zvulunov, A., Barak, Y., & Metzker, A. (1995) · Archives of Dermatology · doi:10.1001/archderm.131.8.904 · Cited by 265
Malignant peripheral nerve sheath tumors in neurofibromatosis 1
King, A. A., Debaun, M. R., Riccardi, V. M., & Gutmann, D. H. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20000828)93:5<388::aid-ajmg8>3.0.co;2-# · Cited by 246
Wu, J., Williams, J. P., Rizvi, T. A., Kordich, J. J., Witte, D., Meijer, D., Stemmer-Rachamimov, A. O., Cancelas, J. A., & Ratner, N. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.027 · Cited by 236
North, K. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(200022)97:2<119::aid-ajmg3>3.0.co;2-3 · Cited by 196
Krab, L. C. (2008) · JAMA · doi:10.1001/jama.300.3.287 · Cited by 193
Plexiform neurofibromas in NF1: Toward biologic-based therapy
Packer, R. J., Gutmann, D. H., Rubenstein, A., Viskochil, D., Zimmerman, R. A., Vezina, G., Small, J., & Korf, B. (2002) · Neurology · doi:10.1212/wnl.58.10.1461 · Cited by 186
Self-citationDistribution of 13 truncating mutations in the neurofibromatosis 1 gene
Heim, R. A., Kam-Morgan, L. N. W., Binnie, C. G., Corns, D. D., Cayouette, M. C., Farber, R. A., Aylsworth, A. S., Silverman, L. M., & Luce, M. C. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.6.975 · Cited by 185
Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients
Ars, E., Kruyer, H., Morell, M., Pros, E., Serra, E., Ravella, A., Estivill, X., & Lázaro, C. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.6.e82 · Cited by 183
Cognitive Profile of Neurofibromatosis Type 1
Levine, T. M., Materek, A., Abel, J., O’Donnell, M., & Cutting, L. E. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.01.006 · Cited by 172
Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene
Kluwe, L., Siebert, R., Gesk, S., Friedrich, R. E., Tinschert, S., Kehrer‐Sawatzki, H., & Mautner, V. (2004) · Human Mutation · doi:10.1002/humu.10299 · Cited by 167
Double Inactivation of NF1 in Tibial Pseudarthrosis
Stevenson, D. A., Zhou, H., Ashrafi, S., Messiaen, L. M., Carey, J. C., D’Astous, J. L., Santora, S. D., & Viskochil, D. H. (2006) · The American Journal of Human Genetics · doi:10.1086/504441 · Cited by 166
Molecular Dissection of Isolated Disease Features in Mosaic Neurofibromatosis Type 1
Maertens, O., De Schepper, S., Vandesompele, J., Brems, H., Heyns, I., Janssens, S., Speleman, F., Legius, E., & Messiaen, L. (2007) · The American Journal of Human Genetics · doi:10.1086/519562 · Cited by 163
Moore, B. D., Slopis, J. M., Schomer, D., Jackson, E. F., & Levy, B. M. (1996) · Neurology · doi:10.1212/wnl.46.6.1660 · Cited by 151
Impact of neurofibromatosis 1 on Quality of Life: A cross‐sectional study of 176 American cases
Page, P. Z., Page, G. P., Écosse, E., Korf, B. R., Leplège, A., & Wolkenstein, P. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31422 · Cited by 151
Self-citationNeurofibromatosis Type 1 Due to Germ-Line Mosaicism in a Clinically Normal Father
Lázaro, C., Ravella, A., Gaona, A., Volpini, V., & Estivill, X. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312102 · Cited by 147
Pathophysiology of Neurofibromatosis Type 1
Theos, A. J., & Korf, B. R. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-11-200606060-00010 · Cited by 146
Self-citationWidemann, B. C., Salzer, W. L., Arceci, R. J., Blaney, S. M., Fox, E., End, D. W., Gillespie, A., Whitcomb, P. O., Palumbo, J. S., Pitney, A. C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8638 · Cited by 145
Decreased bone mineral density in patients with neurofibromatosis 1
Lammert, M., Kappler, M., Mautner, V., Lammert, K., Störkel, S., Friedman, J. M., & Atkins, D. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1940-2 · Cited by 143
The diagnostic value of café-au-lait macules
Landau, M., & Krafchik, B. R. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70075-7 · Cited by 140
Somatic Mutation Analysis in NF1 Café au lait Spots Reveals Two NF1 Hits in the Melanocytes
Schepper, S. D., Maertens, O., Callens, T., Naeyaert, J. M., Lambert, J., & Messiaen, L. M. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701095 · Cited by 125
Ophthalmic manifestations of neurofibromatosis.
Huson, S., Jones, D., & Beck, L. (1987) · British Journal of Ophthalmology · doi:10.1136/bjo.71.3.235 · Cited by 124
Antitumoral Activity of Rapamycin in Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
Wienecke, R., Fackler, I., Linsenmaier, U., Mayer, K., Licht, T., & Kretzler, M. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.05.018 · Cited by 118
ComprehensiveNF1 screening on cultured Schwann cells from neurofibromas
Maertens, O., Brems, H., Vandesompele, J., Raedt, T. D., Heyns, I., Rosenbaum, T., Schepper, S. D., Paepe, A. D., Mortier, G. R., Janssens, S., et al. (2006) · Human Mutation · doi:10.1002/humu.20389 · Cited by 115
Riccardi, V. M., & Lewis, R. A. (1988) · PubMed · Cited by 114
Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1
Lammert, M., Friedman, J. M., Roth, H. J., Friedrich, R. E., Kluwe, L., Atkins, D., Schooler, T., & Mautner, V. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.041095 · Cited by 100
Neurofibromatosis: Phenotype, Natural History, and Pathogenesis
Paller, A. S. (1993) · Archives of Dermatology · doi:10.1001/archderm.1993.01680220135033 · Cited by 93
Neurofibromin, a Tumor Suppressor in the Nervous System
Zhu, Y., & Parada, L. F. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5138 · Cited by 93
Recent insights into bone development, homeostasis, and repair in type 1 neurofibromatosis (NF1)
Schindeler, A., & Little, D. G. (2007) · Bone · doi:10.1016/j.bone.2007.11.006 · Cited by 91
Pigment cell‐related manifestations in neurofibromatosis type 1: an overview
Schepper, S. D., Boucneau, J., Lambert, J., Messiaen, L. M., & Naeyaert, J. (2005) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00206.x · Cited by 85
Goh, W. H. S., Khong, P., Leung, C., & Wong, V. C. N. (2004) · Journal of Child Neurology · doi:10.1177/08830738040190110201 · Cited by 81
Consoli, C., Moss, C., Green, S. A., Balderson, D., Cooper, D. N., & Upadhyaya, M. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23834.x · Cited by 75
Phase II trial of pirfenidone in adults with neurofibromatosis type 1
Babovic‐Vuksanovic, D., Ballman, K. V., Michels, V. V., McGrann, P. S., Lindor, N. M., King, B., Camp, J., Micic, V., Babović, N. L., Carrero, X. W., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000243231.12248.67 · Cited by 72
Phase I Trial of Pirfenidone in Children with Neurofibromatosis 1 and Plexiform Neurofibromas
Babovic‐Vuksanovic, D., Widemann, B. C., Dombi, E., Gillespie, A., Wolters, P. L., Toledo‐Tamula, M. A., O’Neill, B. P., Fox, E., MacDonald, T. J., Beck, H., et al. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.01.009 · Cited by 66
Cutaneous malignant melanoma and neurofibromatosis type 1
Guillot, B., Dalac, S., Delaunay, M. M., Baccard, M., Chevrant‐Breton, J., Dereure, O., Machet, L., Sassolas, B., Zeller, J., Bernard, P., et al. (2004) · Melanoma Research · doi:10.1097/00008390-200404000-00014 · Cited by 52
Multifocal glomus tumours of the fingers in two patients with neurofibromatosis type 1: Figure 1
SMET, L. D., Sciot, R., & Legius, E. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.8.e45 · Cited by 41
Regulated expression of neurofibromin in migrating neural crest cells of avian embryos
Stocker, K. M., Baizer, L., Coston, T., Sherman, L. S., & Ciment, G. (1995) · Journal of Neurobiology · doi:10.1002/neu.480270408 · Cited by 30
Yoshida, Y., Sato, N. A., Furumura, M., & NAKAYAMA, J. (2007) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2007.00258.x · Cited by 21
Gallino, G., Belli, F., Tragni, G., Ferro, F., Massone, P. P. B., Ditto, A., Leo, E., & Cascinelli, N. (2000) · Tumori Journal · doi:10.1177/030089160008600113 · Cited by 18
Lisch nodules in neurofibromatosis.
Ko, W., & Gorovoy, K. (1990) · PubMed · Cited by 9
Cited by
Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas
Welander, J., Söderkvist, P., & Gimm, O. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0170 · Cited by 355
Spooren, W., Lindemann, L., Ghosh, A., & Santarelli, L. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.09.004 · Cited by 119
Jafry, M., & Sidbury, R. (2020) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2020.03.010 · Cited by 40
Xie, R., Fu, K.-I., Chen, S.-M., Tuo, B.-G., & Wu, H.-C. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i33.3806 · Cited by 12
Metadata
- Authors
- Boyd, K. P., Korf, B. R., & Theos, A.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 61
- Issue
- 1
- Pages
- 1-14
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2056866789
- Cited by
- 486
- References
- 63
- FWCI
- 12.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.